(SNEX) Stonex - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8618961085
Stock:
Total Rating 59
Risk 59
Buy Signal 1.33
| Risk 5d forecast | |
|---|---|
| Volatility | 39.8% |
| Relative Tail Risk | -2.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.27 |
| Alpha | 40.46 |
| Character TTM | |
|---|---|
| Beta | 0.977 |
| Beta Downside | 1.494 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.07% |
| CAGR/Max DD | 1.73 |
EPS (Earnings per Share)
Revenue
Description: SNEX Stonex
StoneX Group Inc. operates as a global financial services network that connects companies, organizations, traders, and investors to a market ecosystem in the United States, Europe, South America, the Middle East, Asia, and internationally. The company operates through four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. The Commercial segment provides risk management and hedging, voice brokerage, market intelligence, physical trading, and commodity financing, marketing, procurement, logistics, and price management services; and engages in the risk management and hedging services, execution and clearing of exchange-traded and OTC products. This segment also acts as an institutional dealer in fixed income securities to serve asset managers, commercial bank trust and investment departments, broker-dealers, and insurance companies; and engages in asset management business. The Self-Directed/Retail segment provides trading services and solutions in the global financial markets, including spot foreign exchange, precious metals trading, contracts for differences, and spread bets; and wealth management services, as well as offering physical gold and other precious metals in various forms and denominations through Stonexbullion.com. The company was formerly known as INTL FCStone Inc. and changed its name to StoneX Group Inc. in July 2020. StoneX Group Inc. was founded in 1924 and is headquartered in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 359.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 8.08 > 1.0 |
| NWC/Revenue: 9.18% < 20% (prev 8.41%; Δ 0.77% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.62b > Net Income 359.8m |
| Net Debt (-1.59b) to EBITDA (2.20b): -0.72 < 3 |
| Current Ratio: 341.4 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.7m) vs 12m ago 10.25% < -2% |
| Gross Margin: 2.01% > 18% (prev 0.02%; Δ 198.6% > 0.5%) |
| Asset Turnover: 370.9% > 50% (prev 365.9%; Δ 4.98% > 0%) |
| Interest Coverage Ratio: 1.29 > 6 (EBITDA TTM 2.20b / Interest Expense TTM 1.65b) |
Altman Z'' 2.34
| A: 0.28 (Total Current Assets 13.21b - Total Current Liabilities 38.7m) / Total Assets 47.78b |
| B: 0.04 (Retained Earnings 1.83b / Total Assets 47.78b) |
| C: 0.05 (EBIT TTM 2.12b / Avg Total Assets 38.68b) |
| D: 0.04 (Book Value of Equity 1.82b / Total Liabilities 45.26b) |
| Altman-Z'' Score: 2.34 = BBB |
Beneish M -1.87
| DSRI: 0.87 (Receivables 10.24b/8.90b, Revenue 143.47b/108.25b) |
| GMI: 0.98 (GM 2.01% / 1.97%) |
| AQI: 2.88 (AQ_t 0.72 / AQ_t-1 0.25) |
| SGI: 1.33 (Revenue 143.47b / 108.25b) |
| TATA: -0.07 (NI 359.8m - CFO 3.62b) / TA 47.78b) |
| Beneish M-Score: -1.87 (Cap -4..+1) = B |
What is the price of SNEX shares?
As of February 27, 2026, the stock is trading at USD 128.10 with a total of 292,114 shares traded.
Over the past week, the price has changed by +4.88%, over one month by +21.42%, over three months by +43.93% and over the past year by +61.96%.
Over the past week, the price has changed by +4.88%, over one month by +21.42%, over three months by +43.93% and over the past year by +61.96%.
Is SNEX a buy, sell or hold?
Stonex has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy SNEX.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SNEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 135 | 5.4% |
| Analysts Target Price | 135 | 5.4% |
SNEX Fundamental Data Overview February 21, 2026
P/E Trailing = 18.6095
P/S = 0.0462
P/B = 2.6498
Revenue TTM = 143.47b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.20b USD
Long Term Debt = 19.55b USD (from longTermDebt, last quarter)
Short Term Debt = 488.8m USD (from shortLongTermDebt, last quarter)
Debt = 18.52b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -1.59b USD (from netDebt column, last quarter)
Enterprise Value = 23.48b USD (6.55b + Debt 18.52b - CCE 1.59b)
Interest Coverage Ratio = 1.29 (Ebit TTM 2.12b / Interest Expense TTM 1.65b)
EV/FCF = 6.61x (Enterprise Value 23.48b / FCF TTM 3.55b)
FCF Yield = 15.14% (FCF TTM 3.55b / Enterprise Value 23.48b)
FCF Margin = 2.48% (FCF TTM 3.55b / Revenue TTM 143.47b)
Net Margin = 0.25% (Net Income TTM 359.8m / Revenue TTM 143.47b)
Gross Margin = 2.01% ((Revenue TTM 143.47b - Cost of Revenue TTM 140.60b) / Revenue TTM)
Gross Margin QoQ = 2.29% (prev 2.27%)
Tobins Q-Ratio = 0.49 (Enterprise Value 23.48b / Total Assets 47.78b)
Interest Expense / Debt = 2.64% (Interest Expense 488.0m / Debt 18.52b)
Taxrate = 24.82% (45.9m / 184.9m)
NOPAT = 1.60b (EBIT 2.12b * (1 - 24.82%))
Current Ratio = 341.4 (out of range, set to none) (Total Current Assets 13.21b / Total Current Liabilities 38.7m)
Debt / Equity = 7.34 (Debt 18.52b / totalStockholderEquity, last quarter 2.52b)
Debt / EBITDA = -0.72 (Net Debt -1.59b / EBITDA 2.20b)
Debt / FCF = -0.45 (Net Debt -1.59b / FCF TTM 3.55b)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.93% (Net Income 359.8m / Total Assets 47.78b)
RoE = 16.43% (Net Income TTM 359.8m / Total Stockholder Equity 2.19b)
RoCE = 9.77% (EBIT 2.12b / Capital Employed (Equity 2.19b + L.T.Debt 19.55b))
RoIC = 8.24% (NOPAT 1.60b / Invested Capital 19.36b)
WACC = 3.95% (E(6.55b)/V(25.07b) * Re(9.52%) + D(18.52b)/V(25.07b) * Rd(2.64%) * (1-Tc(0.25)))
Discount Rate = 9.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.95%
[DCF] Terminal Value 80.82% ; FCFF base≈3.55b ; Y1≈2.33b ; Y5≈1.06b
[DCF] Fair Price = 676.9 (EV 33.92b - Net Debt -1.59b = Equity 35.51b / Shares 52.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -69.71 | EPS CAGR: -5.66% | SUE: 3.74 | # QB: 1
Revenue Correlation: 90.17 | Revenue CAGR: 26.05% | SUE: 1.54 | # QB: 10
EPS next Quarter (2026-03-31): EPS=2.02 | Chg7d=+2.020 | Chg30d=+2.020 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=8.31 | Chg7d=+0.780 | Chg30d=+0.780 | Revisions Net=+1 | Growth EPS=+38.0% | Growth Revenue=+0.0%
EPS next Year (2027-09-30): EPS=8.78 | Chg7d=+0.240 | Chg30d=+0.240 | Revisions Net=+1 | Growth EPS=+5.7% | Growth Revenue=+0.0%
P/S = 0.0462
P/B = 2.6498
Revenue TTM = 143.47b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.20b USD
Long Term Debt = 19.55b USD (from longTermDebt, last quarter)
Short Term Debt = 488.8m USD (from shortLongTermDebt, last quarter)
Debt = 18.52b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -1.59b USD (from netDebt column, last quarter)
Enterprise Value = 23.48b USD (6.55b + Debt 18.52b - CCE 1.59b)
Interest Coverage Ratio = 1.29 (Ebit TTM 2.12b / Interest Expense TTM 1.65b)
EV/FCF = 6.61x (Enterprise Value 23.48b / FCF TTM 3.55b)
FCF Yield = 15.14% (FCF TTM 3.55b / Enterprise Value 23.48b)
FCF Margin = 2.48% (FCF TTM 3.55b / Revenue TTM 143.47b)
Net Margin = 0.25% (Net Income TTM 359.8m / Revenue TTM 143.47b)
Gross Margin = 2.01% ((Revenue TTM 143.47b - Cost of Revenue TTM 140.60b) / Revenue TTM)
Gross Margin QoQ = 2.29% (prev 2.27%)
Tobins Q-Ratio = 0.49 (Enterprise Value 23.48b / Total Assets 47.78b)
Interest Expense / Debt = 2.64% (Interest Expense 488.0m / Debt 18.52b)
Taxrate = 24.82% (45.9m / 184.9m)
NOPAT = 1.60b (EBIT 2.12b * (1 - 24.82%))
Current Ratio = 341.4 (out of range, set to none) (Total Current Assets 13.21b / Total Current Liabilities 38.7m)
Debt / Equity = 7.34 (Debt 18.52b / totalStockholderEquity, last quarter 2.52b)
Debt / EBITDA = -0.72 (Net Debt -1.59b / EBITDA 2.20b)
Debt / FCF = -0.45 (Net Debt -1.59b / FCF TTM 3.55b)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.93% (Net Income 359.8m / Total Assets 47.78b)
RoE = 16.43% (Net Income TTM 359.8m / Total Stockholder Equity 2.19b)
RoCE = 9.77% (EBIT 2.12b / Capital Employed (Equity 2.19b + L.T.Debt 19.55b))
RoIC = 8.24% (NOPAT 1.60b / Invested Capital 19.36b)
WACC = 3.95% (E(6.55b)/V(25.07b) * Re(9.52%) + D(18.52b)/V(25.07b) * Rd(2.64%) * (1-Tc(0.25)))
Discount Rate = 9.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.95%
[DCF] Terminal Value 80.82% ; FCFF base≈3.55b ; Y1≈2.33b ; Y5≈1.06b
[DCF] Fair Price = 676.9 (EV 33.92b - Net Debt -1.59b = Equity 35.51b / Shares 52.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -69.71 | EPS CAGR: -5.66% | SUE: 3.74 | # QB: 1
Revenue Correlation: 90.17 | Revenue CAGR: 26.05% | SUE: 1.54 | # QB: 10
EPS next Quarter (2026-03-31): EPS=2.02 | Chg7d=+2.020 | Chg30d=+2.020 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=8.31 | Chg7d=+0.780 | Chg30d=+0.780 | Revisions Net=+1 | Growth EPS=+38.0% | Growth Revenue=+0.0%
EPS next Year (2027-09-30): EPS=8.78 | Chg7d=+0.240 | Chg30d=+0.240 | Revisions Net=+1 | Growth EPS=+5.7% | Growth Revenue=+0.0%